Criteria for successful completion & certificates

For successful completion, participants are required to attend the full activity and complete the program evaluation at the conclusion of the educational event. Your statement of credit will be issued by ADCES once registration (signing in) is confirmed and the evaluation form has been received.  To receive an ADCES-CME certificate of completion, participants must log in, create a profile, and complete the evaluation.  It usually takes one-two weeks for the ADCES to verify attendance & evaluation completion to update your profile with the CE certificate.

** If you need more assistance with your ADCES profile, please call 800-338-3633 ext. 3.

CREDIT INFORMATION

The 2022 Diabetes Conference has received approval for continuing education from the following entity:

In support of improving patient care, the Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the Association of Social Work Boards (ASWB), the American Academy of PAs (AAPA), the Commission on Dietetic Registration (CDR) and the Certification Board for Diabetes Care & Education (CBDCE) to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive up to 11.5 Continuing Education (CE) credits for learning and change.

Disclosures

Disclosures and Mitigation of Relevant Conflicts of Interest:

Planning Committee: Melissa House, Jessie Fernandes, Marci Butcher, Katie Pipinich, Susan Day, and Michelle Eckert

Speakers: Stewart Perry, Erin Callahan, Jerry Meece, James Bennett, Marcus Paske, Kellie Wilson, Jennifer Van Syckle, Kate Thomas, Tolly Patten, Gary Scheiner, Haley Cote, Brian P. Bost, Allison Pollock, Patty Kosednar, Betsy Kubacka, Jason Gleason, Carla Cox, Jessica Peterson, Kristine Kilen, Katie Pipinich, and Will Tedrow

There is no conflict of interest for anyone in a position to control the content of this activity, except for:

• Jerry Meece is on the Speaker Bureau for Novo Nordisk, Lifescan Inc, Sanofi and a consultant for Lifescan Inc., Johnson and Johnson, Novo Nordisk, Medtronic

• Gary Scheiner who is on the Speaker Bureau for Dexcom, Medtronic/Companion Medical, Eli Lilly, Xeris, and a consultant for Adocia, Ascensia, Byram Healthcare, Capillary Biomedical, Klinio, Mannkind, Modular Medical, Provention Bio, Triple Jump, Ypsomed

• Betsy Kubacka who is employed by Glytec LLC,makers of Glucommander and has stock in Glytec ** Note - This will be a non-CE presentation.

• Kris Kilen who is employed by Novo Nordisk

All relevant financial relationships have been mitigated. 

• For all 3 Presenters, mitigation was completed by contacting each presenter to discuss potential bias, balance, evidence-based content, integrity, and absence of bias. All slide decks were reviewed and show no evidence of bias or influence.  The presentations will be monitored during the event, and evaluation responses will be reviewed to ensure that the presentation is balanced and free of bias.